Inventor · disambiguated record
Peter Francis
Also filed as: FRANCIS PETER · FRANCIS PETER J
9 granted patents·10 pending applications·19 citations·filing 2005–2025
84Inventor score
Files with4D MOLECULAR THERAPEUTICS INC14JANSSEN PHARMACEUTICA NV2CUBIC CORP1RAY THERAPEUTICS INC1UNIV OREGON HEALTH & SCIENCE1
Top patents by PatentIndex Score
19 records- 0195US11802278B2Codon optimized GLA genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Oct 31, 2023·3 cites·10 claims
- 0293US11198858B2Codon optimized GLA genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Dec 14, 2021·2 cites·23 claims
- 0392US11345930B2Codon optimized RPGRORF15 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted May 31, 2022·2 cites·25 claims
- 0489US11499166B2Adeno-associated variants, formulations and methods for pulmonary delivery4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Nov 15, 2022·2 cites·12 claims
- 0588US11807868B2Adeno-associated variants, formulations and methods for pulmonary delivery4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·1 cites·28 claims
- 0688US11766489B2Adeno-associated virus variant capsids and use for inhibiting angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2018·Granted Sep 26, 2023·5 cites·33 claims
- 0787US2024358859A1Codon optimized rep1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0880US11524081B2Codon optimized REP1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Dec 13, 2022·0 cites·20 claims
- 0980US7557197B2Human soluble neuropilin-1 primary polyadenylation signal and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2005·Granted Jul 7, 2009·4 cites·29 claims
- 1079US2024018498A1Codon optimized gla genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1179US2023158172A1Codon optimized rep1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1278US11357870B2Codon optimized REP1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Jun 14, 2022·0 cites·25 claims
- 1375US2024067987A1Adeno-associated variants, formulations and methods for pulmonary delivery4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1468US2022290181A1Codon optimized rpgrorf15 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1564US2024335560A1Adeno-associated virus variant capsids and use for inhibiting angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1660US2025387513A1Gene therapy compositions and methods for treating diseases of the retinaRAY THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1754US2025170146A1Niraparib and abiraterone acetate plus prednisone to improve clinical outcomes in patients with metastatic castration-resistant prostate cancer and hrr alterationsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1854US2024325369A1Treatment of metastatic castration-resistant prostate cancer with niraparibJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1948US2023056050A1Gate access panel double hingeCUBIC CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Francis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →